MEP27908A - Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium - Google Patents

Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium

Info

Publication number
MEP27908A
MEP27908A MEP-279/08A MEP27908A MEP27908A ME P27908 A MEP27908 A ME P27908A ME P27908 A MEP27908 A ME P27908A ME P27908 A MEP27908 A ME P27908A
Authority
ME
Montenegro
Prior art keywords
coli
leu
production
signal sequences
hirudine
Prior art date
Application number
MEP-279/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Paul Habermann
Rudolf Bender
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of MEP27908A publication Critical patent/MEP27908A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MEP-279/08A 1999-09-18 2000-09-01 Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium MEP27908A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944870A DE19944870A1 (de) 1999-09-18 1999-09-18 Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium
PCT/EP2000/008537 WO2001021662A1 (de) 1999-09-18 2000-09-01 Signalsequenzen zur herstellung von leu-hirudin über sekretion durch e. coli in das kulturmedium

Publications (1)

Publication Number Publication Date
MEP27908A true MEP27908A (en) 2010-10-10

Family

ID=7922547

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-279/08A MEP27908A (en) 1999-09-18 2000-09-01 Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium

Country Status (29)

Country Link
US (1) US7455987B1 (no)
EP (1) EP1216259B1 (no)
JP (1) JP4669181B2 (no)
KR (1) KR100737189B1 (no)
CN (2) CN1192037C (no)
AR (1) AR025660A1 (no)
AT (1) ATE357458T1 (no)
AU (1) AU775923B2 (no)
BR (1) BR0014519A (no)
CA (1) CA2385287C (no)
CZ (1) CZ2002899A3 (no)
DE (2) DE19944870A1 (no)
DK (1) DK1216259T3 (no)
EE (1) EE05187B1 (no)
HK (2) HK1049172A1 (no)
HR (1) HRP20020226B1 (no)
HU (1) HUP0202596A3 (no)
IL (2) IL148624A0 (no)
ME (1) MEP27908A (no)
MX (1) MXPA02002469A (no)
NO (1) NO329723B1 (no)
NZ (1) NZ517825A (no)
PL (1) PL205117B1 (no)
RS (1) RS50435B (no)
RU (1) RU2261867C2 (no)
SK (1) SK287865B6 (no)
TR (2) TR200501541T2 (no)
WO (1) WO2001021662A1 (no)
ZA (1) ZA200202106B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
EP1687324B1 (en) * 2003-11-21 2012-08-22 Pfenex, Inc. Improved expression systems with sec-system secretion
EP1774017B1 (en) 2004-07-26 2013-05-15 Pfenex Inc. Process for improved protein expression by strain engineering
DE102005046113A1 (de) * 2005-09-27 2007-03-29 Sanofi-Aventis Deutschland Gmbh Verfahren zur Amidierung von Polypetiden mit C-terminalen basischen Aminosäuren unter Verwendung spezifischer Endoproteasen
DE102006044841A1 (de) * 2006-09-22 2008-04-03 Wacker Chemie Ag Signalpeptid zur Produktion von rekombinanten Proteinen
JP5714230B2 (ja) 2007-01-31 2015-05-07 フェネックス インコーポレイテッド 発現上昇のための細菌リーダー配列
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9394571B2 (en) 2007-04-27 2016-07-19 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
DK2968470T3 (da) 2013-03-12 2021-02-01 Massachusetts Gen Hospital Modificeret müllersk inhiberende substans (mis)-proteiner og anvendelser deraf til behandlingen af sygdomme
US11135269B2 (en) 2013-12-11 2021-10-05 The General Hospital Corporation Use of mullerian inhibiting substance (MIS) proteins for contraception and ovarian reserve preservation
CN108220369B (zh) * 2017-12-04 2021-03-12 广东双骏生物科技有限公司 一种生产重组水蛭素的方法
CN108359689B (zh) * 2018-01-19 2021-03-23 华中农业大学 利用抗病基因识别无毒效应蛋白以鉴定具有分泌功能信号肽的方法
CN115572329B (zh) * 2021-06-21 2024-02-06 王大勇 一组活性增强代谢较慢的菲牛蛭基因重组水蛭素及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
DE58903988D1 (de) * 1985-04-11 1993-05-13 Hoechst Ag Hirudin-derivat.
US5084384A (en) * 1987-04-23 1992-01-28 Monsanto Company Secretion of insulin-like growth factor-I
AU604925B2 (en) * 1988-02-23 1991-01-03 Schering Aktiengesellschaft A hirudin derivative
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
DK0511393T3 (da) * 1990-11-08 1996-12-09 Japan Energy Corp Hirudin-mutant, fremstilling af denne, antikoagulant, sekretorisk vektor, mikroorganisme transformeret af vektoren og fremstilling af produkt ud fra mikroorganismen
JPH07119237B2 (ja) * 1990-11-08 1995-12-20 株式会社ジャパンエナジー ヒルジン変異体，その製造法及び抗凝血剤
US5389529A (en) * 1991-06-12 1995-02-14 Regeneron Pharmaceuticals, Inc. Modified lamβ signal sequence and processes for producing recombinant neurotrophins
NZ243084A (en) * 1991-06-12 1995-08-28 Regeneron Pharma Production and recovery of recombinant neurotrophins, genes for a modified lamb signal sequence, fusion genes and plasmids
DE4140381A1 (de) 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet

Also Published As

Publication number Publication date
EE05187B1 (et) 2009-06-15
HRP20020226A2 (en) 2004-04-30
CA2385287C (en) 2010-10-19
RU2002110278A (ru) 2004-03-27
PL354444A1 (en) 2004-01-12
WO2001021662A1 (de) 2001-03-29
CN1550502A (zh) 2004-12-01
AR025660A1 (es) 2002-12-11
EP1216259A1 (de) 2002-06-26
TR200501541T2 (tr) 2005-06-21
NO329723B1 (no) 2010-12-06
AU775923B2 (en) 2004-08-19
RU2261867C2 (ru) 2005-10-10
SK287865B6 (sk) 2012-02-03
JP2003510041A (ja) 2003-03-18
HRP20020226B1 (en) 2010-08-31
KR20020034188A (ko) 2002-05-08
CN1192037C (zh) 2005-03-09
HK1049172A1 (en) 2003-05-02
PL205117B1 (pl) 2010-03-31
ATE357458T1 (de) 2007-04-15
ZA200202106B (en) 2003-01-09
EP1216259B1 (de) 2007-03-21
NZ517825A (en) 2004-07-30
US7455987B1 (en) 2008-11-25
DK1216259T3 (da) 2007-07-02
EE200200139A (et) 2003-06-16
HK1068352A1 (en) 2005-04-29
DE50014189D1 (de) 2007-05-03
HUP0202596A2 (hu) 2002-12-28
IL148624A0 (en) 2002-09-12
BR0014519A (pt) 2002-06-11
CZ2002899A3 (cs) 2002-06-12
MXPA02002469A (es) 2002-08-28
SK3622002A3 (en) 2003-06-03
YU14602A (sh) 2005-07-19
CN1374970A (zh) 2002-10-16
IL148624A (en) 2009-08-03
HUP0202596A3 (en) 2005-01-28
RS50435B (sr) 2009-12-31
NO20021254D0 (no) 2002-03-13
JP4669181B2 (ja) 2011-04-13
CA2385287A1 (en) 2001-03-29
TR200200667T2 (tr) 2002-06-21
AU6842100A (en) 2001-04-24
KR100737189B1 (ko) 2007-07-10
CN1269838C (zh) 2006-08-16
DE19944870A1 (de) 2001-03-29
NO20021254L (no) 2002-05-07

Similar Documents

Publication Publication Date Title
MEP27908A (en) Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium
NO20033673L (no) Fusjonsprotein for sekresjon av et protein av interesse til supernatanten til en bakteriekultur
DK0612350T3 (da) Ubiquitin-specifikke proteaser
CY1109698T1 (el) Κρυσταλλικη εποθιλονη d
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
ATE510214T1 (de) Krankheitsdiagnose
DK0981630T3 (da) Polypeptider med prolyldipeptidylaminopeptidaseaktivitet og nukleinsyrer, der koder for samme
DE602005013263D1 (de) Reinigung von glykopeptiden
EP1487966A4 (en) SECRETION OF PROTEINS WITH MULTIPLE DISULFIDE BINDINGS IN BACTERIA AND USES THEREOF
ATE343369T1 (de) Neue verwendung von proteinhydrolysaten
IT1250692B (it) Procedimento per la preparazione di demetilepipodofillotossina- beta-d-glucosidi.
DE602006014140D1 (de) Mit scytovirin der domäne 1 verwandte polypeptide
NL1025542A1 (nl) Geanelleerde heteroarylcarbonzuren als PPAR-agonisten.
IS6799A (is) Bætt aðferð við framleiðslu á milliefni gabapentíns
DE50014445D1 (de) Estergruppenspaltendes enzym aus thermomonospora fusca
WO2002033093A3 (en) Aggrecanase molecules
WO2005057486A3 (en) Protein engineering with analogous contact environments
ITMO20030160A0 (it) Impianto per la depurazione dei fiumi provenienti,in particolare,dalla produzione di fritte ceramiche.
DE69202858D1 (de) Herstellungsverfahren für chymosin.
WO2003104400A3 (en) SECRETARY SIGNAL SEQUENCES AND THEIR USES
CY1116631T1 (el) Καθαρισμος πρωτεϊνων με τεχνικη μη-συγγενειας
DK1444244T3 (da) Fremgangsmåde til fremstilling af desclarithromycin, samt mellemprodukter
WO2002034895A3 (en) Novel aggrecanase molecules
ITRM20020287A0 (it) Cellule di lievito ingegnerizzate per la produzione di proteine ricombinanti.
EA200300741A1 (ru) Способ получения малеата амлодипина